Recombinogenic and mutagenic effects of the antitumor antibiotic bleomycin in Aspergillus nidulans.
Bleomycin, an antibiotic and antineoplastic drug that inhibits DNA synthesis and causes several types of chromosomal aberration, was found to increase mitotic recombination in Aspergillus nidulans. Heterozygous prototrophic diploid strains grown on media containing bleomycin produced significant increases of yellow and white sectors compared with controls. Further, the increased colour segregants were due to mitotic crossing-over, whereas the non-dis junctional segregants remained at the control level. Bleomycin also induced point mutations in the methionine-suppressor system of the methGl biAl strain of Aspergillus nidulans. Conidia treated in suspension with various concentrations of bleomycin increased the methionine-independent mutants 30-fold and more.
D001233:Aspergillus nidulans / Q000187:drug effects / Q000235:genetics*; D001761:Bleomycin / Q000494:pharmacology*; D002869:Chromosome Aberrations; D004171:Diploidy; D008040:Genetic Linkage; D008938:Mitosis / Q000187:drug effects; D009153:Mutagens; D009154:Mutation; D011995:Recombination, Genetic / Q000187:drug effects*
D009153:Mutagens; D001761:Bleomycin